N@N

HPY, KIE, GIII, LMAT, KALU, HALO Are Seasonally Ripe To Go Up In the Next Five Weeks

^{Published on 2012-08-09 04:01:14 - WOPRAI}
 

August 9, 2012 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of HEARTLAND PAYMENT SYSTEMS, INC. (NYSE:HPY), Kbw Insurance Etf (NYSE:KIE), G-III Apparel Group Ltd (NASDAQ:GIII), LeMaitre Vascular Inc (NASDAQ:LMAT), Kaiser Aluminum Corp (NASDAQ:KALU), Halozyme Therapeutics Inc (NASDAQ:HALO) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/strat/mh.php

The following stocks are expected to go Up:

  Symbol  Company                          Expected Return  Odds                 By The Following Date
  HPY     HEARTLAND PAYMENT SYSTEMS, INC.  7.42%            66.67% (4 of 6)      Tuesday, September 4th 2012
  KIE     Kbw Insurance Etf                3.86%            100.00% (6 of 6)     Tuesday, September 11th 2012
  GIII    G-III Apparel Group Ltd          19.15%           90.91% (10 of 11)    Friday, September 14th 2012
  LMAT    LeMaitre Vascular Inc            9.70%            100.00% (5 of 5)     Friday, September 14th 2012
  KALU    Kaiser Aluminum Corp             15.47%           66.67% (4 of 6)      Friday, September 14th 2012
  HALO    Halozyme Therapeutics  Inc       9.35%            87.50% (7 of 8)      Thursday, August 30th 2012

Kbw Insurance Etf (NYSE:KIE) - ST KBW INSURANCE

G-III Apparel Group Ltd (NASDAQ:GIII) - G-III Apparel Group, Ltd., together with its subsidiaries, designs, manufactures, imports, and markets a range of outerwear and sportswear apparel to retailers primarily in the United States. It offers womens dresses and suits; sportswear, including coats, jackets, pants, and skirts; accessories comprising womens handbags and mens carrying cases; womens footwear; mens accessories; and mens cold weather accessories. The company also produces apparel under its own proprietary brands, including Andrew Marc, Marc New York, Jessica Howard, Eliza J, Black Rivet, G-III and G-III Sports by Carl Banks, Winlit, and Marvin Richards. It sells its products under licensed brands, own proprietary brands, and private retail labels. The company primarily provides its products to upper tier stores, department stores, specialty stores, and catalogs. It also holds licenses to produce branded fashion apparel under the Calvin Klein, Sean John, Kenneth Cole, Cole Haan, Guess, Guess?, Jones New York, Jessica Simpson, Nine West, Ellen Tracy, Tommy Hilfiger, Enyce, Levis, and Dockers brands. The company also holds sports licenses with the National Football League, National Basketball Association, Major League Baseball, National Hockey League, Touch by Alyssa Milano, and with the United States colleges and universities. As of January 31, 2010, it operated 121 retail stores in 35 states, of which 118 are outlet stores operated under the Wilsons Leather name. The company was founded in 1956 and is based in New York, New York.

LeMaitre Vascular Inc (NASDAQ:LMAT) - LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants for the treatment of peripheral vascular disease worldwide. The companys endovascular products include LeverEdge contrast injector for injection of contrast media into blood vessels; TAArget thoracic stent graft for use in the endovascular repair of thoracic aortic aneurysm and dissection; the UnBalloon non-occlusive modeling catheter for improvement in the seal of aortic stent grafts; and VascuTape radiopaque tape for improvement in precision of vascular and endovascular procedures. Its vascular products consist of AlboGraft vascular grafts for in bypass and replacement procedures; AlboSure and XenoSure vascular patches for use in closing incisions in a blood vessel; AnastoClip vessel closure system for attaching blood vessels primarily for dialysis access; EndoRE remote endarterectomy devices for removal of blockages in the arteries of the leg; expandable LeMaitre valvulotome for destruction of vein valves to create vein bypass grafts; InvisiGrip vein stripper for single-incision removal of varicose veins; LeMaitre balloon catheters for removal of blood clots, occlusion, and facilitation of blood flow; and Pruitt-Inahara, Pruitt F3, and Flexcel carotid shunts for facilitating blood flow to brain during carotid plaque removal. The companys products in general surgery category comprise reddick cholangiogram catheter for introduction of dye into the cystic duct; and OptiLock implantable port for central venous infusion of drugs and nutrients. In addition, LeMaitre distributes Powerlink system, a bifurcated abdominal stent graft, as well as engages in private label manufacturing. It sells its products through direct sales force and a network of distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was founded in 1983 and is headquartered in Burlington, Massachusetts.

Kaiser Aluminum Corp (NASDAQ:KALU) - Kaiser Aluminum Corporation manufactures semi-fabricated aluminum products primarily in the United States, Canada, and the United Kingdom. The company produces rolled, extruded, drawn, and forged aluminum products used for aerospace and defense, automotive, consumer durables, electronics, electrical, and machinery and equipment end-use applications. It manufactures products in three categories, such as aerospace and high strength products, general engineering products, and custom automotive and industrial products. The companys aerospace and high strength products include heat treat plates and sheets, cold finish bars, seamless drawn tubes, and billets. Its general engineering products include alloy rod, bar, tube, sheet, plate, and standard extrusions. The companys rod and bar products are manufactured into rivets, nails, screws, bolts, and parts of machinery and equipment. Its custom automotive and industrial products consist of extruded/drawn and forged aluminum products for automotive and industrial end uses, including consumer durables, electrical/electronic, machinery and equipment, automobile, light truck, heavy truck, and truck trailer applications. The companys products include extruded products for bumpers and anti-lock braking systems, drawn tube for drive shafts, and forgings for suspension control arms and drive train yokes. It primarily serves aerospace companies, automotive suppliers, and metal distributors. The company was founded in 1987 and is headquartered in Foothill Ranch, California.

Halozyme Therapeutics Inc (NASDAQ:HALO) - Halozyme Therapeutics, Inc., a biopharmaceutical company, engages in the development and commercialization of products targeting the extracellular matrix for the endocrinology, oncology, dermatology, and drug delivery markets. Its portfolio of products and product candidates is based on intellectual property covering the family of human enzymes known as hyaluronidases and additional enzymes that affect the extracellular matrix. The companys Enhanze technology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. It has partnerships with F. Hoffmann-La Roche, Ltd and Hoffmann-La Roche, Inc. to apply Enhanze Technology to Roches biological therapeutic compounds for up to 13 targets; and with Baxter Healthcare Corporation to apply Enhanze Technology to Baxters biological therapeutic compound, GAMMAGARD LIQUID, as well as to develop and supply active pharmaceutical ingredient for HYLENEX, a product used as an adjuvant to increase the dispersion and absorption of other injected drugs and fluids. The company was founded in 1998 and is based in San Diego, California.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641